PEDF: Anti-angiogenic guardian of ocular function

Trends in Molecular Medicine

Volumn 8, Issue 7, 2002, Pages 330-334

  Bouck, Noël ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANGIOGENESIS INHIBITOR; PIGMENT EPITHELIUM DERIVED FACTOR;

ANGIOGENESIS; BLINDNESS; BLOOD VESSEL INJURY; CLINICAL TRIAL; CORRELATION ANALYSIS; DRUG MECHANISM; DRUG TOLERABILITY; GENE THERAPY; HUMAN; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; RETINA MACULA DEGENERATION; REVIEW; SIDE EFFECT; VISION;

ANGIOGENESIS INHIBITORS; ENDOTHELIUM, VASCULAR; EYE; EYE DISEASES; EYE PROTEINS; HUMANS; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PATHOLOGIC; NERVE GROWTH FACTORS; OCULAR PHYSIOLOGY; PROTEINS; SERPINS;

ADENOVIRIDAE;

EID: 0036300131     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(02)02362-6     Document Type: Review

References (45)

1. The management of retinopathy of prematurity
2. The Wisconsin Epidemiologic study of diabetic retinopathy
3. Age-related macular degeneration
4. How tumors become angiogenic
5. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
6. Suppression of retinal neovascularization in vitro by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins
7. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration
8. Nonvascular role for VEGF: VEGFR- 1,2 activity is critical for neural retinal development
9. Pigment epithelium-derived factor: A potent inhibitor of angiogenesis
10. Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration
11. Structure-function studies on PEDF a noninhibitory serpin with neurotrpohic activity
12. PEDF: Raising both hopes and questions in controlling angiogenesis
13. Pigment epithelium-derived factor supports normal development of photoreceptor neurons and opsin expression after retinal pigment epithelium removal
14. Pigment epithelium-derived factor delays the death of photoreceptors in mouse models of inherited retinal degenerations
15. In vitro protection of photoreceptors from light damage by pigment epithelium-derived factor
16. Structural and comparative analysis of the mouse gene for pigment epithelium-derived factor (PEDF)
17. Binding of pigment epithelium- derived factor (PEDF) to retinoblastoma cells and cerebellar granule neurons
18. Evidence for pigment epithelium-derived factor receptors in the neural retina
19. Prevention ofischemia induced retinopathy by the natural ocular anti-angiogenic agent pigment epithelium-derived factor
20. Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor
21. Angiogenesis in wound healing
22. The Fas death factor
23. Role of NF-kappaB-mediated interleukin-8 expression in intraocular neovascularization
24. More weapons in the arsenal against ischemic retinopathy
25. Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization
26. Novel mechanism for age-related macular degeneration: An equilibrium shift between the angiogenesis factors VEGF and PEDF
27. Difference in ischemic regulation of vascular endothehal growth factor and pigment epithelium -derived factor in brown Norway and Sprague Dawley rats contributing to different susceptibilities to retinal neovascularization
28. Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease
29. Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment
30. Pigment epithelium-derived factor (PEDF), an endogenous angiogenesis inhibitor is down regulated in ocular tissues in proliferative retinopathy
31. Expression, secretion and age-related downregulation of pigment epithelium-derived factor, a serpin with neurotrophic activity
32. Senescence of the retinal pigment epithelium
33. Pigment epithelium-derived factor (PEDF) in neuroblastoma: A multifunctional mediator of Schwann cell antitumor activity
34. Angiogenesis therapy: Amidst the hype, the neglected potential for serious side effects
35. Endogenous angiogenesis inhibitors and their therapeutic implications
36. Crystal structure of human PEDF, a potent anti-angiogenic and neurite growth-promoting factor
37. Pigment epithehum-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth
38. Fluocinolone acetonide sustained drug delivery device to treat severe uveitis
39. Intravitreous transplantation of encapsulated fibroblasts secreting the human fibroblast growth factor 2 delays photoreceptor cell degeneration in Royal College of Surgeons rats
40. Looking into anti-angiogenic gene therapies for disorders of the eye
41. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization
42. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD)
43. Localization of pigment epithelium derived factor (PEDF) in developing and adult human ocular tissues
44. Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization
45. Endogenous inhibitors of angiogenesis